Additionally, four trials included 334 individuals with chronic health conditions (cancer, cerebral palsy, inflammatory bowel disease, obesity), all of whom had anemia (Hb < 11.5 g/dL) [20, 27, 32, 37]. Here, GSTM1 is linked to cancer.